Get in touch to find out more

Thank you for your submission!

Oops! Something went wrong while submitting the form.

Transforming curative cancer treatments

Oxford Cancer Analytics is transforming curative cancer treatments through a minimally invasive blood test and machine learning.

Detecting cancer early, offering hope for patients and families

We are on a mission to save lives and drastically improve cancer management through early detection, with machine learning and an affordable blood test

Join our team
OXcan team

We are focused on lung cancer

Oxford Cancer Analytics focuses on strategic beachhead markets in lung cancer for expedited product deployment.

Applying state-of-the-art machine learning for multidimensional liquid biopsy data with a focus on protein enables maximised detection accuracy compared to leading competitors.

OXcan has international partnerships focussing on all aspects of lung cancer management, from high risk screening, to early recurrence detection and personalised treatment stratification.

OXcan team

Dr. Peter Jianrui Liu
Dr. Peter Jianrui Liu

Chief Executive Officer

Andreas Halner
Andreas Halner

President & Chief Operating Officer

Dr. Junetha Syed Jabarulla
Dr. Junetha Syed Jabarulla

Chief Scientist

Dr. Zhu Liang
Dr. Zhu Liang

Proteomic Scientist

Francesco Pozzetti
Francesco Pozzetti

Machine Learning Scientist

Dr. Daniel Szulc
Dr. Daniel Szulc

Partnerships and Development Manager

Dr. Ella Mi
Dr. Ella Mi

Medical Affairs and Regulatory Manager

Rosaria Rosaria
Rosaria Rosaria

Business Analyst

Luke Hankey
Luke Hankey

Machine Learning Programmer

Amani Ali
Amani Ali

Graphic Designer

David Litchfield
David Litchfield

Content Creator

Board and Advisors

Brad Wilson
Brad Wilson

Chairman

Marcus East
Marcus East

Non-Executive Director

Dr. Chengzhi Wang
Dr. Chengzhi Wang

Non-Executive Director

Professor Benedikt Kessler
Professor Benedikt Kessler

Scientific Advisor

Supporters and Partners

Learn more about our collaborations

Find out more

Awards

All Innovate Ideas Competition

Overall Winner

Accelerating Oncology Innovations

Ones to watch for 2021

KQ Labs Francis Crick Institute supported company

1 in 10 annually

Cancer Research UK Alderley Park Oncology Programme Grant

1 in 8 annually

Contact us

Oxford
3-5 Hythe Bridge Street
Oxford,
Oxfordshire,
OX1 2EW,
UK

Toronto
Banting Institute,
100 College St, Suite 150,
Toronto, ON,
M5G 1L5,
Canada

Get in touch